.png)
Antacids Market By Dosage and Distribution Channel - Global Industry Analysis & Forecast to 2027
Published On : March 2019 Pages : 170 Category: Pharma & Healthcare Report Code : HC032956
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Antacids Market By Dosage (Liquid, Tablet, Others) Distribution Channel (Retail pharmacy, Hospital pharmacy, Online pharmacy) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Antacids Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Antacids are utilized to treat heartburn that causes indigestion, heartburn, and stomach upset. They give brisk alleviation from acid reflux, which is a noteworthy side effect of gastroesophageal reflux illness and heartburn. Treatment with stomach settling agents is symptomatic and is normally suggested for minor indications. Acid neutralizers incorporate magnesium trisilicate, aluminum hydroxide, and aluminum hydroxide.
Drivers and Restraints
Changing dietary propensities is one of the central point expected to fuel the development amid the conjecture time frame. Expanding commonness of Gastro Esophageal Reflux Diseases (GERD) is anticipated to influence the general market over the gauge time frame. Moreover, expanding mindfulness about GERD is foreseen to help the antacids market. Also, expanding pervasiveness of indigestion is evaluated to influence the market over the estimate time frame.
Regional Insights
Europe represented the biggest offer in the antacids market in 2022 because of variables, for example, expanded frequency of gastroesophageal reflux sicknesses and developing geriatric populace.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer AG
- Boehringer Ingelheim International
- Reckitt Benckiser Group plc.
- Sun Pharmaceuticals Ltd
- Procter & Gamble
- GlaxoSmithkline plc
- Pfizer, Inc
- Dr. Reddy’s Laboratories Ltd.
- Sanofi
- Takeda Pharmaceutical Company Limited
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Antacids Market, By Dosage, Estimates and Forecast, 2017-2027 ($Million)
· Liquid
· Tablet
· Others
· Antacids Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
· Retail pharmacy
· Hospital pharmacy
· Online pharmacy
· Antacids Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
· North America
§ North America Antacids Market, By Country
o U.S. Antacids Market
o Canada Antacids Market
o Mexico Antacids Market
· Europe
§ Europe Antacids Market, By Country
o Germany Antacids Market
o UK Antacids Market
o France Antacids Market
o Russia Antacids Market
o Italy Antacids Market
o Rest of Europe Antacids Market
· Asia-Pacific
§ Asia-Pacific Antacids Market, By Country
o China Antacids Market
o Japan Antacids Market
o South Korea Antacids Market
o India Antacids Market
o Southeast Asia Antacids Market
o Rest of Asia-Pacific Antacids Market
· South America
§ South America Antacids Market
o Brazil Antacids Market
o Argentina Antacids Market
o Columbia Antacids Market
o Rest of South America Antacids Market
· Middle East and Africa
§ Middle East and Africa Antacids Market
o Saudi Arabia Antacids Market
o UAE Antacids Market
o Egypt Antacids Market
o Nigeria Antacids Market
o South Africa Antacids Market
o Rest of MEA Antacids Market
Antacids Market, By Key Players
· Bayer AG
· Boehringer Ingelheim International
· Reckitt Benckiser Group plc.
· Sun Pharmaceuticals Ltd
· Procter & Gamble
· GlaxoSmithkline plc
· Pfizer, Inc
· Dr. Reddy’s Laboratories Ltd.
· Sanofi
· Takeda Pharmaceutical Company Limited
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Antacids Market, By Dosage
5.1. Introduction
5.2. Global Antacids Revenue and Market Share by Dosage (2017-2027)
5.2.1. Global Antacids Revenue and Revenue Share by Dosage (2017-2027)
5.3. Liquid
5.3.1. Global Liquid Revenue and Growth Rate (2017-2027)
5.4. Tablet
5.4.1. Global Tablet Revenue and Growth Rate (2017-2027)
5.5. Others
5.5.1. Global Others Revenue and Growth Rate (2017-2027)
6. Antacids Market, By Distribution Channel
6.1. Introduction
6.2. Global Antacids Revenue and Market Share by Distribution Channel (2017-2027)
6.2.1. Global Antacids Revenue and Revenue Share by Distribution Channel (2017-2027)
6.3. Retail pharmacy
6.3.1. Global Retail pharmacy Revenue and Growth Rate (2017-2027)
6.4. Hospital pharmacy
6.4.1. Global Hospital pharmacy Revenue and Growth Rate (2017-2027)
6.5. Online pharmacy
6.5.1. Global Online pharmacy Revenue and Growth Rate (2017-2027)
7. Antacids Market, By Region
7.1. Introduction
7.2. Global Antacids Revenue and Market Share by Regions
7.2.1. Global Antacids Revenue by Regions (2017-2027)
7.3. North America Antacids by Countries
7.3.1. North America Antacids Revenue and Growth Rate (2017-2027)
7.3.2. North America Antacids Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Antacids by Countries
7.4.1. Europe Antacids Revenue and Growth Rate (2017-2027)
7.4.2. Europe Antacids Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Antacids by Countries
7.5.1. Asia-Pacific Antacids Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Antacids Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Antacids by Countries
7.6.1. South America Antacids Revenue and Growth Rate (2017-2027)
7.6.2. South America Antacids Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Antacids by Countries
7.7.1. Middle East and Africa Antacids Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Antacids Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Bayer AG
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Boehringer Ingelheim International
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Reckitt Benckiser Group plc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Sun Pharmaceuticals Ltd
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Procter & Gamble
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. GlaxoSmithkline plc
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Pfizer, Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Dr. Reddy’s Laboratories Ltd.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Sanofi
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Takeda Pharmaceutical Company Limited
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Global Antacids Market Competition, by Manufacturer
9.1. Global Antacids Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Antacids Price By Region (2017-2017)
9.3. Top 5 Antacids Manufacturer Market Share
9.4. Market Competition Trend
10. Antacids Market Forecast (2017-2027)
10.1. Global Antacids Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Antacids Market Forecast by Regions (2017-2027)
10.2.1. North America Antacids Market Forecast (2017-2027)
10.2.1.1. United States Antacids Market Forecast (2017-2027)
10.2.1.2. Canada Antacids Market Forecast (2017-2027)
10.2.1.3. Mexico Antacids Market Forecast (2017-2027)
10.2.2. Europe Antacids Market Forecast (2017-2027)
10.2.2.1. Germany Antacids Market Forecast (2017-2027)
10.2.2.2. France Antacids Market Forecast (2017-2027)
10.2.2.3. UK Antacids Market Forecast (2017-2027)
10.2.2.4. Russia Antacids Market Forecast (2017-2027)
10.2.2.5. Italy Antacids Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Antacids Market Forecast (2017-2027)
10.2.3. Asia-Pacific Antacids Market Forecast (2017-2027)
10.2.3.1. China Antacids Market Forecast (2017-2027)
10.2.3.2. Japan Antacids Market Forecast (2017-2027)
10.2.3.3. Korea Antacids Market Forecast (2017-2027)
10.2.3.4. India Antacids Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Antacids Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Antacids Market Forecast (2017-2027)
10.2.4. South America Antacids Market Forecast (2017-2027)
10.2.4.1. Brazil Antacids Market Forecast (2017-2027)
10.2.4.2. Argentina Antacids Market Forecast (2017-2027)
10.2.4.3. Columbia Antacids Market Forecast (2017-2027)
10.2.4.4. Rest of South America Antacids Market Forecast (2017-2027)
10.2.5. Middle East and Africa Antacids Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Antacids Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Antacids Market Forecast (2017-2027)
10.2.5.3. Egypt Antacids Market Forecast (2017-2027)
10.2.5.4. Nigeria Antacids Market Forecast (2017-2027)
10.2.5.5. South Africa Antacids Market Forecast (2017-2027)
10.2.5.6. Turkey Antacids Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Antacids Market Forecast (2017-2027)
10.3. Antacids Market Forecast by Dosage (2017-2027)
10.3.1. Antacids Forecast by Dosage (2017-2027)
10.3.2. Antacids Market Share Forecast by Dosage (2017-2027)
10.4. Antacids Market Forecast by Distribution Channel (2017-2027)
10.4.1. Antacids Forecast by Distribution Channel (2017-2027)
10.4.2. Antacids Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Antacids Revenue and Revenue Share by Dosage (2017-2018)
Figure Global Liquid Revenue and Growth Rate (2017-2018)
Figure Global Tablet Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Antacids Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Retail pharmacy Revenue and Growth Rate (2017-2018)
Figure Global Hospital pharmacy Revenue and Growth Rate (2017-2018)
Figure Global Online pharmacy Revenue and Growth Rate (2017-2018)
Table Global Antacids Revenue by Regions (2017-2018)
Figure North America Antacids Growth Rate (2017-2018)
Figure North America Antacids Revenue and Growth Rate (2017-2018)
Figure North America Antacids by Countries (2017-2018)
Figure North America Antacids Revenue (Million USD) by Countries (2017-2018)
Figure United States Antacids Growth Rate (2017-2018)
Figure United States Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Antacids Growth Rate (2017-2018)
Figure Canada Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Antacids Growth Rate (2017-2018)
Figure Mexico Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Antacids Growth Rate (2017-2018)
Figure Europe Antacids Revenue and Growth Rate (2017-2018)
Figure Europe Antacids by Countries (2017-2018)
Figure Europe Antacids Revenue (Million USD) by Countries (2017-2018)
Figure Germany Antacids Growth Rate (2017-2018)
Figure Germany Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Antacids Growth Rate (2017-2018)
Figure France Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Antacids Growth Rate (2017-2018)
Figure UK Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Antacids Growth Rate (2017-2018)
Figure Russia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Antacids Growth Rate (2017-2018)
Figure Italy Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Antacids Growth Rate (2017-2018)
Figure Rest of Europe Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Antacids Growth Rate (2017-2018)
Figure Asia-Pacific Antacids Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Antacids by Countries (2017-2018)
Figure Asia-Pacific Antacids Revenue (Million USD) by Countries (2017-2018)
Figure China Antacids Growth Rate (2017-2018)
Figure China Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Antacids Growth Rate (2017-2018)
Figure Japan Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Antacids Growth Rate (2017-2018)
Figure Korea Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Antacids Growth Rate (2017-2018)
Figure India Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Antacids Growth Rate (2017-2018)
Figure Southeast Asia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antacids Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Antacids Growth Rate (2017-2018)
Figure South America Antacids Revenue and Growth Rate (2017-2018)
Figure South America Antacids by Countries (2017-2018)
Figure South America Antacids Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Antacids Growth Rate (2017-2018)
Figure Brazil Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Antacids Growth Rate (2017-2018)
Figure Argentina Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Antacids Growth Rate (2017-2018)
Figure Columbia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Antacids Growth Rate (2017-2018)
Figure Rest of South America Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Antacids Growth Rate (2017-2018)
Figure Middle East and Africa Antacids Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Antacids by Countries (2017-2018)
Figure Middle East and Africa Antacids Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Antacids Growth Rate (2017-2018)
Figure Saudi Arabia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Antacids Growth Rate (2017-2018)
Figure United Arab Emirates Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Antacids Growth Rate (2017-2018)
Figure Egypt Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Antacids Growth Rate (2017-2018)
Figure Nigeria Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Antacids Growth Rate (2017-2018)
Figure South Africa Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Antacids Growth Rate (2017-2018)
Figure Turkey Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antacids Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer AG Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim International Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Reckitt Benckiser Group plc. Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sun Pharmaceuticals Ltd Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Procter & Gamble Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithkline plc Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer, Inc Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dr. Reddy’s Laboratories Ltd. Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Takeda Pharmaceutical Company Limited Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Antacids Market Share by Manufacturer
Figure Global Antacids Revenue and Market Share by Manufacturer
Table Global Antacids Price by Region (2017-2017)
Figure Top 5 Antacids Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Antacids Revenue (Millions USD) and Growth Rate (2018-2025)
Table Antacids Market Forecast by Regions (2018-2025)
Figure North America Antacids Market Forecast (2018-2025)
Figure United States Antacids Market Forecast (2018-2025)
Figure Canada Antacids Market Forecast (2018-2025)
Figure Mexico Antacids Market Forecast (2018-2025)
Figure Europe Antacids Market Forecast (2018-2025)
Figure Germany Antacids Market Forecast (2018-2025)
Figure France Antacids Market Forecast (2018-2025)
Figure UK Antacids Market Forecast (2018-2025)
Figure Russia Antacids Market Forecast (2018-2025)
Figure Italy Antacids Market Forecast (2018-2025)
Figure Rest of Europe Antacids Market Forecast (2018-2025)
Figure Asia-Pacific Antacids Market Forecast (2018-2025)
Figure China Antacids Market Forecast (2018-2025)
Figure Japan Antacids Market Forecast (2018-2025)
Figure Korea Antacids Market Forecast (2018-2025)
Figure India Antacids Market Forecast (2018-2025)
Figure Southeast Asia Antacids Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Antacids Market Forecast (2018-2025)
Figure South America Antacids Market Forecast (2018-2025)
Figure Brazil Antacids Market Forecast (2018-2025)
Figure Argentina Antacids Market Forecast (2018-2025)
Figure Columbia Antacids Market Forecast (2018-2025)
Figure Rest of South America Antacids Market Forecast (2018-2025)
Figure Middle East and Africa Antacids Market Forecast (2018-2025)
Figure Saudi Arabia Antacids Market Forecast (2018-2025)
Figure United Arab Emirates Antacids Market Forecast (2018-2025)
Figure Egypt Antacids Market Forecast (2018-2025)
Figure Nigeria Antacids Market Forecast (2018-2025)
Figure South Africa Antacids Market Forecast (2018-2025)
Figure Turkey Antacids Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Antacids Market Forecast (2018-2025)
Figure Global Antacids Forecast by Dosage (2018-2025)
Figure Global Antacids Market Share Forecast by Dosage (2018-2025)
Figure Global Antacids Forecast by Dosage (2018-2025)
Figure Global Antacids Forecast by Distribution Channel (2018-2025)
Figure Global Antacids Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Antacids Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
List of Figures
List of Tables and Figures:
Figure United States Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Antacids Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Antacids Revenue and Revenue Share by Dosage (2017-2018)
Figure Global Liquid Revenue and Growth Rate (2017-2018)
Figure Global Tablet Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Antacids Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Retail pharmacy Revenue and Growth Rate (2017-2018)
Figure Global Hospital pharmacy Revenue and Growth Rate (2017-2018)
Figure Global Online pharmacy Revenue and Growth Rate (2017-2018)
Table Global Antacids Revenue by Regions (2017-2018)
Figure North America Antacids Growth Rate (2017-2018)
Figure North America Antacids Revenue and Growth Rate (2017-2018)
Figure North America Antacids by Countries (2017-2018)
Figure North America Antacids Revenue (Million USD) by Countries (2017-2018)
Figure United States Antacids Growth Rate (2017-2018)
Figure United States Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Antacids Growth Rate (2017-2018)
Figure Canada Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Antacids Growth Rate (2017-2018)
Figure Mexico Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Antacids Growth Rate (2017-2018)
Figure Europe Antacids Revenue and Growth Rate (2017-2018)
Figure Europe Antacids by Countries (2017-2018)
Figure Europe Antacids Revenue (Million USD) by Countries (2017-2018)
Figure Germany Antacids Growth Rate (2017-2018)
Figure Germany Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Antacids Growth Rate (2017-2018)
Figure France Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Antacids Growth Rate (2017-2018)
Figure UK Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Antacids Growth Rate (2017-2018)
Figure Russia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Antacids Growth Rate (2017-2018)
Figure Italy Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Antacids Growth Rate (2017-2018)
Figure Rest of Europe Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Antacids Growth Rate (2017-2018)
Figure Asia-Pacific Antacids Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Antacids by Countries (2017-2018)
Figure Asia-Pacific Antacids Revenue (Million USD) by Countries (2017-2018)
Figure China Antacids Growth Rate (2017-2018)
Figure China Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Antacids Growth Rate (2017-2018)
Figure Japan Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Antacids Growth Rate (2017-2018)
Figure Korea Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Antacids Growth Rate (2017-2018)
Figure India Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Antacids Growth Rate (2017-2018)
Figure Southeast Asia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antacids Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Antacids Growth Rate (2017-2018)
Figure South America Antacids Revenue and Growth Rate (2017-2018)
Figure South America Antacids by Countries (2017-2018)
Figure South America Antacids Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Antacids Growth Rate (2017-2018)
Figure Brazil Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Antacids Growth Rate (2017-2018)
Figure Argentina Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Antacids Growth Rate (2017-2018)
Figure Columbia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Antacids Growth Rate (2017-2018)
Figure Rest of South America Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Antacids Growth Rate (2017-2018)
Figure Middle East and Africa Antacids Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Antacids by Countries (2017-2018)
Figure Middle East and Africa Antacids Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Antacids Growth Rate (2017-2018)
Figure Saudi Arabia Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Antacids Growth Rate (2017-2018)
Figure United Arab Emirates Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Antacids Growth Rate (2017-2018)
Figure Egypt Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Antacids Growth Rate (2017-2018)
Figure Nigeria Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Antacids Growth Rate (2017-2018)
Figure South Africa Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Antacids Growth Rate (2017-2018)
Figure Turkey Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antacids Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antacids Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer AG Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim International Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Reckitt Benckiser Group plc. Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sun Pharmaceuticals Ltd Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Procter & Gamble Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithkline plc Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer, Inc Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dr. Reddy’s Laboratories Ltd. Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Takeda Pharmaceutical Company Limited Antacids Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Antacids Market Share by Manufacturer
Figure Global Antacids Revenue and Market Share by Manufacturer
Table Global Antacids Price by Region (2017-2017)
Figure Top 5 Antacids Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Antacids Revenue (Millions USD) and Growth Rate (2018-2025)
Table Antacids Market Forecast by Regions (2018-2025)
Figure North America Antacids Market Forecast (2018-2025)
Figure United States Antacids Market Forecast (2018-2025)
Figure Canada Antacids Market Forecast (2018-2025)
Figure Mexico Antacids Market Forecast (2018-2025)
Figure Europe Antacids Market Forecast (2018-2025)
Figure Germany Antacids Market Forecast (2018-2025)
Figure France Antacids Market Forecast (2018-2025)
Figure UK Antacids Market Forecast (2018-2025)
Figure Russia Antacids Market Forecast (2018-2025)
Figure Italy Antacids Market Forecast (2018-2025)
Figure Rest of Europe Antacids Market Forecast (2018-2025)
Figure Asia-Pacific Antacids Market Forecast (2018-2025)
Figure China Antacids Market Forecast (2018-2025)
Figure Japan Antacids Market Forecast (2018-2025)
Figure Korea Antacids Market Forecast (2018-2025)
Figure India Antacids Market Forecast (2018-2025)
Figure Southeast Asia Antacids Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Antacids Market Forecast (2018-2025)
Figure South America Antacids Market Forecast (2018-2025)
Figure Brazil Antacids Market Forecast (2018-2025)
Figure Argentina Antacids Market Forecast (2018-2025)
Figure Columbia Antacids Market Forecast (2018-2025)
Figure Rest of South America Antacids Market Forecast (2018-2025)
Figure Middle East and Africa Antacids Market Forecast (2018-2025)
Figure Saudi Arabia Antacids Market Forecast (2018-2025)
Figure United Arab Emirates Antacids Market Forecast (2018-2025)
Figure Egypt Antacids Market Forecast (2018-2025)
Figure Nigeria Antacids Market Forecast (2018-2025)
Figure South Africa Antacids Market Forecast (2018-2025)
Figure Turkey Antacids Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Antacids Market Forecast (2018-2025)
Figure Global Antacids Forecast by Dosage (2018-2025)
Figure Global Antacids Market Share Forecast by Dosage (2018-2025)
Figure Global Antacids Forecast by Dosage (2018-2025)
Figure Global Antacids Forecast by Distribution Channel (2018-2025)
Figure Global Antacids Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Antacids Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|